Syros Pharmaceuticals (SYRS) Announces Voluntary Delisting from Nasdaq Feb 28, 2025 04:07PM
Syros Pharmaceuticals (SYRS) Halted, News Pending Feb 28, 2025 04:00PM
H.C. Wainwright Downgrades Syros Pharmaceuticals (SYRS) at Neutral Nov 13, 2024 06:52AM
TD Cowen Downgrades Syros Pharmaceuticals (SYRS) to Hold Nov 13, 2024 02:58AM
JMP Securities Downgrades Syros Pharmaceuticals (SYRS) to Market Perform Nov 13, 2024 02:57AM


Nov 12, 2024 04:30PM Syros Pharmaceuticals (SYRS) Reports Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene
Oct 31, 2024 07:33AM Syros Pharmaceuticals (SYRS) Tops Q3 EPS by 52c, provides cash guidance
Oct 23, 2024 07:41AM Piper Sandler Reiterates Overweight Rating on Syros Pharmaceuticals (SYRS)
Aug 13, 2024 09:54AM TD Cowen Reiterates Buy Rating on Syros Pharmaceuticals (SYRS)
Aug 13, 2024 09:15AM Syros Pharmaceuticals (SYRS) PT Lowered to $5 at Piper Sandler
Aug 13, 2024 06:20AM Syros Pharmaceuticals (SYRS) PT Lowered to $6 at H.C. Wainwright
Aug 12, 2024 04:16PM Syros Pharmaceuticals (SYRS) Provides Update on SELECT-AML-1 Phase 2 Clinical Trial
Jul 31, 2024 07:30AM Syros Pharmaceuticals (SYRS) Tops Q2 EPS by 18c
Jun 26, 2024 09:23AM TD Cowen Reiterates Buy Rating on Syros Pharmaceuticals (SYRS)
Jun 26, 2024 07:48AM Piper Sandler Reiterates Overweight Rating on Syros Pharmaceuticals (SYRS)
Jun 26, 2024 06:39AM H.C. Wainwright Reiterates Buy Rating on Syros Pharmaceuticals (SYRS)
Jun 26, 2024 05:26AM Brookline Capital Markets Reiterates Buy Rating on Syros Pharmaceuticals (SYRS)
Jun 25, 2024 04:08PM JMP Securities Reiterates Market Outperform Rating on Syros Pharmaceuticals (SYRS)
Jun 18, 2024 08:45AM Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions